Author Topic: ((Abst.) Association of sustained immunotherapy w/disability outcomes in patients w/active SPMS  (Read 39 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest

From JAMA Neurology (November 2020)--"Association of sustained immunotherapy with disability outcomes in patients with active secondary progressive multiple sclerosis":


https://bit.ly/38BYFdU
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
108 Views
Last post March 13, 2019, 02:56:48 pm
by agate
4 Replies
192 Views
Last post November 21, 2019, 07:14:23 am
by agate
0 Replies
39 Views
Last post July 27, 2020, 02:08:41 pm
by agate
0 Replies
23 Views
Last post March 21, 2022, 09:21:08 pm
by agate
0 Replies
19 Views
Last post April 09, 2022, 07:09:40 am
by agate